期刊文献+

碳酸镧联合血液灌流对比碳酸镧联合血液透析滤过对降低慢性肾衰竭患者血磷和减轻皮肤瘙痒的临床疗效观察

Clinical efficacy observations of lanthanum carbonate combined with blood perfusion versus lanthanum carbonate combined with hemodialysis filtration on the reduction of serum phosphorus and skin itch for chronic renal failure patients
下载PDF
导出
摘要 目的探究碳酸镧联合血液灌流对比碳酸镧联合血液透析滤过在降低慢性肾衰竭患者血磷和减轻皮肤瘙痒中的应用价值。方法将江门市新会区第二人民医院在2022年5月~2023年5月期间收治的88例慢性肾衰竭并高磷血症伴皮肤瘙痒患者作为本次研究对象,通过随机数字表法获得对照组(44例,口服碳酸镧咀嚼片联合血液透析滤过治疗)与研究组(44例,口服碳酸镧咀嚼片联合血液灌流治疗),比较两组患者治疗效果、治疗前后血钙、血磷与甲状腺素,并发症发生率与皮肤瘙痒改善情况。结果与对照组治疗总有效率81.82%相比,研究组95.45%较高(P<0.05)。治疗前,两组患者血钙、血磷以及甲状腺素水平差异无统计学意义(P>0.05),治疗后,两组患者血钙水平上升,血磷与甲状腺素水平均降低,其中,与对照组相比,研究组各指标变化幅度较大(P<0.05)。和对照组相比,研究组并发症总发生率较低(13.64%vs.2.27%),皮肤瘙痒改善率较高(75.00%vs.90.91%)(P<0.05)。结论与碳酸镧联合血液透析滤过治疗相比,在慢性肾衰竭患者中应用碳酸镧联合血流灌注治疗效果较优,能够有效改善患者血钙、血磷与甲状腺素水平,提升皮肤瘙痒改善率与治疗效果。 Objective To explore the applied value of lanthanum carbonate combined with blood perfusion versus lanthanum carbonate combined with hemodiacysis filtration on the reduction of serum phosphorus and skin itch for chronic renal failure patients.Methods 88 chronic renal failure patients with hyperphosphatemia and skin itch admitted to The Second People’s Hospital of Xinhui District(2022.5~2023.5)were chosen as research subjects.According to random number table,patients were assigned to the control group(n=44,lanthanum carbonate tablets combined with hemodiacysis filtration)and the study group(n=44,lanthanum carbonate combined with blood perfusion).Treatment effects,serum calcium,serum phosphorus,thyroxine before and after treatment,clinical complications and skin itch improvement condition were compared.Results The total effective treatment rates in the study group(95.45%)were higher than the control group(81.82%)(P<0.05);before treatment,serum calcium,serum phosphorus and thyroxine contents between groups were not significantly different(P>0.05);after treatment,serum calcium contents for two groups were increased while serum phosphorus and thyroxine contents were reduced.The fluctuation degrees of serum calcium,serum phosphorus and thyroxine contents in the study group were even higher than the control group(P<0.05);the total complication rates in the study group were lower than the control group(13.64%vs.2.27%);the skin itch improvement rates in the study group were higher than the control group(75.00%vs.90.91%,P<0.05).Conclusion Compared to lanthanum carbonate combined with hemodialysis filtration,the application of lanthanum carbonate combined with blood perfusion in patients with chronic renal failure has a better effect.It can effectively improve the levels of serum calcium,serum phosphorus,and thyroid levels in patients,and enhance the skin itch improvement rates and treatment effect.
作者 尹晓晖 黄杰贤 郭海燕 余雅婷 邓国强 YIN Xiao-hui;HUANG Jie-xian;GUO Hai-yan(Pharmacy Department,The Second People’s Hospital of Xinhui District,Jiangmen 529100,China.)
出处 《中国处方药》 2024年第4期110-112,共3页 Journal of China Prescription Drug
基金 江门市科技计划项目(2022YL08021)。
关键词 碳酸镧 血液灌流 血液透析滤过 慢性肾衰竭 高磷血症 Lanthanum carbonate Blood perfusion Hemofiltration Chronic renal failure Hyperphosphatemia
  • 相关文献

参考文献13

二级参考文献133

  • 1王淑荣.碳酸镧联合不同血液净化方式对慢性肾脏病矿物质及骨代谢异常患者的影响[J].世界最新医学信息文摘,2019,0(103):46-47. 被引量:3
  • 2Nora V.Bergasa,E.Anthony Jones.Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis[J].Journal of Clinical and Translational Hepatology,2017,5(3):203-207. 被引量:18
  • 3陈伟,崔天蕾,谢林伸,李昕怡,吴敬.不同血液净化方式对维持性血液透析患者微炎症状态和营养状态的影响[J].中国老年学杂志,2015,35(2):379-380. 被引量:45
  • 4Gorriz JL, Molina P, Bover J, et al. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study[J]. Ne- frologia, 2013, 33(1): 46-60.
  • 5Koiwa F, Maruta Y. Chronic kidney disease-mineral and bonedisorder(CKD-MBD): role of cinacalcet in the treatment of CKD-MBD[J]. Clin Calcium, 2010, 20(7): 1089-1095.
  • 6Block GA, Wheeler DC, Persky MS, et al. Effects of phos- phate binders in moderate CKD[J]. J Am Soc Nephrol, 2012, 23(8) : 1407-1415.
  • 7Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis[J]. J Am Med Assoc, 2011, 305(11) : 1119-1127.
  • 8Naves-Diaz M, Passliek-Deetjen J, Guinsburg A, et al. Calci- um, phosphorus, PTH and death rates in a large sample of di- alysis patients from Latin America.- the CoRES Study[J]. Nephrol Dial Transplant, 2011, 26(6): 1938-1947.
  • 9National KF. K/DOQI clinical practice guidelines for bone me- tabolism and disease in chronic kidney disease[J]. Am J Kid- ney Dis, 2003, 42(Suppl 3): $1- $201.
  • 10Daugirdas JT, Chertow GM, Larive B, et al. Effects of fre- quent hemodialysis on measues of CKD mineral and bone disor- der[J]. J Am Soc Nephrol, 2012, 23(4): 727-738.

共引文献412

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部